The relation of lower urinary tract symptoms with life-style factors and objective measures of benign prostatic enlargement and obstruction: An italian survey

European Urology

Volumn 45, Issue 6, 2004, Pages 767-772

  Tubaro, Andrea ^a,c   La Vecchia, Carlo ^b  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Epidemiology; Prostatic hyperplasia; Symptoms; Urodynamics

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGE DISTRIBUTION; AGED; ANTIGEN DETECTION; DISEASE SEVERITY; ECHOGRAPHY; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MICTURITION; ORGAN WEIGHT; PRIORITY JOURNAL; PROSTATE; PROSTATE HYPERTROPHY; QUALITY OF LIFE; REVIEW; RISK ASSESSMENT; SYMPTOMATOLOGY; URINARY TRACT OBSTRUCTION; URODYNAMICS;

EID: 2442630363     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eururo.2004.01.011     Document Type: Article

References (20)

1. Berry S.J., Coffey D.S., Walsh P.C., Ewing L.L. The development of human benign prostatic hyperplasia with age. J. Urol. 132:1984;474-479
2. Hald T. Urodynamics in benign prostatic hyperplasia: a survey. Prostate Suppl. 2:1989;69-77
3. Garraway W.M., Russell E.B.A.W., Lee R.J., Collins G.N., McKelvie G.B., Hehir M., et al. Impact of previously unrecognised benign prostatic hyperplasia on the daily activities of middle-aged and elderly men. Br. J. Gen. Pract. 43:1993;318-321
4. Chute C.G., Panser L.A., Girman C.J., Oesterling J.E., Guess H.A., Jacobsen S.J., et al. The prevalence of prostatism: a population-based survey of urinary symptoms. J. Urol. 150:1993;85-89
5. Tsukamoto T., Kumamoto Y., Masumori N., Miyake H., Rhodes T., Girman C.J., et al. Prevalence of prostatism in Japanese men in a community-based study with comparison to a similar American study. J. Urol. 154:1995;391-395
6. Chapple C.R. BPH disease management: Introduction and concluding remarks. Eur. Urol. 36(Suppl 3):1999;1-6
7. Girman C.J., Jacobsen S.J., Guess H.A., Oesterling J.E., Chute C.G., Panser L.A., et al. Natural history of prostatism: relationship among symptoms, prostate volume and peak urinary flow rate. J. Urol. 153:1995;1510-1515
8. Barry M.J., Cockett A.T., Holtgrewe H.L., McConnell J.D., Siheinik S.A., Winfield H.N. Relationship of symptoms of prostatism to commonly used physiological and anatomical measures of the severity of benign prostatic hyperplasia. J. Urol. 150:1993;351-358
9. Wadie B.S., Ibrahim E.I., de la Rosette J.J., Gomha M.A., Ghoneim M.A. The relationship of the international prostate symptom score and objective parameters for diagnosing bladder outlet obstruction. Part I: when statistics fail. J. Urol. 165:2001;32-34
10. Eckhardt M.D., van Venrooij G.E.P.M., Boon T.A. Symptoms and quality of life versus age, prostate volume and urodynamic parameters in 565 strictly selected men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia. Urology. 57(4):2001;695-700
11. Sirls L.T., Kirkemo A.K., Jay J. Lack of correlation of the American Urological Association Symptom 7 index with urodynamic bladder outlet obstruction. Neurourol. Urodyn. 15:1996;447-456
12. Barry M.J., Fowler F.J., O'Leary M.P., Bruskewitz R.C., Holtgrewe H.L., Mebust W.K., et al. The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association. J. Urol. 148:1992;1549-1557
13. Abrams P., Cardozo L., Fail M., Griffiths D., Rosier P., Ulmsten U., et al. The Standardisation of terminology of lower urinary tract function: report from the Standardisation Subcommittee of the International Continence Society. Neurourol. Urodyn. 21:2002;167
14. Chatelain C, Denis L, Foo KT, et al., editors. Proceedings of the 5th International Consultation on Benign Prostatic Hyperplasia (BPH), June 25-28, 2000, Paris. Plymouth: Health Publication Ltd.; 2001.
15. Hunter D.J.W., McKee M., Black N.A., Sanderson C.F.B. Health status and quality of life of British men with lower urinary tract symptoms: results from the SF-36. Urology. 45:1995;962-971
16. Elbadawi D.J.W., McKee M., Black N.A., Sanderson C.F.B. Health status and quality of life of British men with lower urinary tract symptoms: results from the SF-36. Urology. 45:1995;962-971
17. Welch G., Kawachi I., Barry M.J., Giovannucci E., Colditz G.A., Willett W.C. Distinction between symptoms of voiding and filling in benign prostatic hyperplasia: finding from the health professionals follow-up study. Urology. 51:1998;422-427
18. Speakman M.J. The causes of lower urinary tract symptoms in patients. Drugs Today. 37(Suppl D):2001;3-6
19. Roehrborn C.G., Girman C.J., Rhodes T., Hanson K.A., Collins G.N., Sech S.M., et al. Correlation between prostate size estimated by digital rectal examination and measured by transrectal ultrasound. Urology. 49:1997;548-557
20. Roehrborn C.G., McConnel J., Bonilla J., et al. for the Proscar long term efficacy and safety study. Serum Prostate specific antigen is a strong predictor of future prostate growth in men with benign prostatic hyperplasia. J. Urol. 163:2000;13-20